A review of current evidence suggests circulating tumor DNA has significant prognostic and predictive potential for detecting minimal residual disease and individualizing adjuvant therapy in colorectal cancer. (Klinická Onkologie)
Circulating Tumor DNA Shows Promise for Predicting Colorectal Cancer Recurrence
The CRC Digest